The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Phenothiazine: the seven lives of pharmacology's first lead structure
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Biochemistry of Oxidative Stress
Sies, H. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198610581 · Cited by 1,306
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Geddes, J., Freemantle, N., Harrison, P., & Bebbington, P. (2000) · BMJ · doi:10.1136/bmj.321.7273.1371 · Cited by 1,062
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
The physiology of brain histamine
Brown, R. E., Stevens, D. R., & Haas, H. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00039-3 · Cited by 988
The physiological action of β‐iminazolylethylamine
Dale, H. H., & Laidlaw, P. P. (1910) · The Journal of Physiology · doi:10.1113/jphysiol.1910.sp001406 · Cited by 884
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
Snyder, S. H., Banerjee, S. P., Yamamura, H. I., & Greenberg, D. (1974) · Science · doi:10.1126/science.184.4143.1243 · Cited by 834
A Survey of Drug-Induced Extrapyramidal Reactions
Ayd, F. J. (1961) · JAMA · doi:10.1001/jama.1961.03040120016004 · Cited by 753
The Regulation of Reactive Oxygen Species Production during Programmed Cell Death
Tan, S., Sagara, Y., Liu, Y., Maher, P., & Schubert, D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.6.1423 · Cited by 730
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Golden Age of Insecticide Research: Past, Present, or Future?
Casida, J. E., & Quistad, G. B. (1998) · Annual Review of Entomology · doi:10.1146/annurev.ento.43.1.1 · Cited by 666
Toxic drug effects associated with oxygen metabolism: Redox cycling and lipid peroxidation
Kappus, H., & Sies, H. (1981) · Experientia · doi:10.1007/bf01948335 · Cited by 642
Dietary polyphenols: Good, bad, or indifferent for your health?
HALLIWELL, B. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.004 · Cited by 559
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.
Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M., & Harrington, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11213 · Cited by 547
Wiesner, J., Ortmann, R., Jomaa, H., & Schlitzer, M. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200569 · Cited by 428
The creation of psychopharmacology
(2002) · Choice Reviews Online · doi:10.5860/choice.40-0332 · Cited by 423
Genetics of dopamine receptors and drug addiction: a comprehensive review
Foll, B. L., Gallo, A., Strat, Y. L., Lu, L., & Gorwood, P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 393
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
Stone, J. M., Morrison, P. D., & Pilowsky, L. S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073126 · Cited by 348
A history of antipsychotic drug development
Shen, W. W. (1999) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(99)90082-2 · Cited by 273
Methylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways
Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H., & Ames, B. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9610com · Cited by 272
Antioxidants as treatment for neurodegenerative disorders
Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 252
Self-citationPHARMACOKINETIC AND CLINICAL STUDIES IN PATIENTS WITH CIMETIDINE-ASSOCIATED MENTAL CONFUSION
Schentag, J., Calleri, G., Rose, J., Cerra, F., Deglopper, E., & Bernhard, H. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90578-6 · Cited by 237
Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureus
Kaatz, G. W., Moudgal, V. V., Seo, S. M., & Kristiansen, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.719-726.2003 · Cited by 224
Methylene blue as an antimalarial agent
Schirmer, R. H., Coulibaly, B., Stich, A., Scheiwein, M., Merkle, H., Eubel, J., Becker, K., Becher, H., Müller, O., Zich, T., et al. (2003) · Redox Report · doi:10.1179/135100003225002899 · Cited by 220
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007) · Biochemistry · doi:10.1021/bi700411k · Cited by 213
Behl, C., & Moosmann, B. (2002) · Biological Chemistry · doi:10.1515/bc.2002.053 · Cited by 203
Self-citationHorn, A. S., & Snyder, S. H. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.10.2325 · Cited by 198
A method to determine the ability of drugs to diffuse through the blood-brain barrier.
Seelig, A., Gottschlich, R., & Devant, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.68 · Cited by 197
Nybäck, H., & Sedvall, G. (1968) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28031-4 · Cited by 176
The potential management of resistant infections with non-antibiotics
Kristiansen, J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.319 · Cited by 174
Hippius, H. (1989) · Psychopharmacology · doi:10.1007/bf00442551 · Cited by 168
Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S., & Rubin, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508844200 · Cited by 150
CATIE and CUtLASS: can we handle the truth?
Lewis, S. W., & Lieberman, J. A. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.037218 · Cited by 149
Meissner, P. E., Mandi, G., Coulibaly, B., Witte, S., Tapsoba, T. L., Mansmann, U., Rengelshausen, J., Schiek, W., Jahn, A., Walter‐Sack, I., et al. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-84 · Cited by 131
Excitotoxicity, apoptosis and neuropsychiatric disorders
Olney, J. W. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00002-4 · Cited by 130
Buhrmester, C., Moshurchak, L., Wang, R. L., & Dahn, J. R. (2006) · Journal of The Electrochemical Society · doi:10.1149/1.2140615 · Cited by 125
[Therapeutic method derived from hiberno-therapy in excitation and agitation states].
Delay, J., Deniker, P., & Jm, H. (1952) · PubMed · Cited by 124
Effect of Chlorpromazine on the Behaviour of Chronically Overactive Psychotic Patients
Elkes, J., & Elkes, C. (1954) · BMJ · doi:10.1136/bmj.2.4887.560 · Cited by 119
Methylene blue prevents neurodegeneration caused by rotenone in the retina
Zhang, X., Rojas, J. C., & Gonzalez-Lima, F. (2006) · Neurotoxicity Research · doi:10.1007/bf03033307 · Cited by 118
Courvoisier, S., Fournel, J., DUCROT, R., Kolsky, M., & Koetschet, P. (1953) · PubMed · Cited by 118
TREATMENT OF SCHIZOPHRENIC REACTIONS WITH PHENOTHIAZINE DERIVATIVES
Casey, J. F., Lasky, J. J., Klett, C. J., & Hollister, L. E. (1960) · American Journal of Psychiatry · doi:10.1176/ajp.117.2.97 · Cited by 115
Reversal of resistance in microorganisms by help of non-antibiotics
Kristiansen, J. E., Hendricks, O., Delvin, T., Butterworth, T. S., Aagaard, L., Christensen, J. B., Flores, V. C., & Keyzer, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm071 · Cited by 109
The spurious advance of antipsychotic drug therapy
Tyrer, P. J., & Kendall, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61765-1 · Cited by 106
[Artificial hibernation by pharmacodynamical and physical means].
Laborit, H., & Huguenard, P. (1951) · PubMed · Cited by 86
Phenothiazine: The Parent Molecule
Mitchell, S. C. (2006) · Current Drug Targets · doi:10.2174/138945006778226552 · Cited by 85
Methylene Blue Provides Behavioral and Metabolic Neuroprotection Against Optic Neuropathy
Rojas, J. C., John, J. M., Lee, J., & Gonzalez-Lima, F. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9027-z · Cited by 72
Aeschlimann, C., Cerny, T., & Kupfer, A. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08471-5 · Cited by 71
Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death
Moosmann, B., Skutella, T., Beyer, K., & Behl, C. (2001) · Biological Chemistry · doi:10.1515/bc.2001.195 · Cited by 70
Self-citationMadrid, P. B., Polgar, W. E., Toll, L., & Tanga, M. J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.064 · Cited by 66
Striatal neuroprotection with methylene blue
Rojas, J. C., Simola, N., Kermath, B. A., Kane, J. R., Schallert, T. J., & Gonzalez-Lima, F. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.07.012 · Cited by 62
Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum
Furian, A. F., Fighera, M. R., Oliveira, M. S., Ferreira, A. P. D. O., Fiorenza, N. G., Myskiw, J. D. C., Petry, J. C., Coelho, R. C., Mello, C. F., & Royes, L. F. F. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.07.012 · Cited by 50
THE ANTIBACTERIAL EFFECT OF SELECTED PHENOTHIAZINES AND THIOXANTHENES ON SLOW‐GROWING MYCOBACTERIA
Kristiansen, J. E., & Vergmann, B. (1986) · Acta Pathologica Microbiologica Scandinavica Section B Microbiology · doi:10.1111/j.1699-0463.1986.tb03073.x · Cited by 49
Hajieva, P., Mocko, J. B., Moosmann, B., & Behl, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06114.x · Cited by 49
Self-citationPhenothiazines as lipid peroxidation inhibitors and cytoprotective agents
Yu, M. J., McCowan, J. R., Thrasher, K. J., Keith, P. T., Luttman, C. A., Ho, P. P. K., Towner, R. D., Bertsch, B., & Horng, J. S. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00082a012 · Cited by 46
Mocko, J. B., Kern, A., Moosmann, B., Behl, C., & Hajieva, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.019 · Cited by 46
Self-citationHendricks, O., Butterworth, T. S., & Kristiansen, J. E. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00205-x · Cited by 41
Peters, R. J., Yacoubian, G. S., Rhodes, W. A., et al. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10400614 · Cited by 33
Chlorpromazine in nonpsychotic patients with pulmonary tuberculosis.
Hollister, L. E., EIKENBERRY, D. T., & Raffel, S. (1960) · PubMed · doi:10.1164/arrd.1960.81.4.562 · Cited by 29
THE ACTION OF PROMETHAZINE (PHENERGAN) IN PROTECTING MICE AGAINST DEATH DUE TO HISTAMINE
Halpern, B. N., & Wood, D. R. (1950) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1950.tb00603.x · Cited by 21
Dietary Phenols: Antioxidants for the Brain?
Moosmann, B., & Behl, C. (2000) · Nutritional Neuroscience · doi:10.1080/1028415x.2000.11747298 · Cited by 17
Self-citationIn vitro Activity of Phenothiazine Derivatives in Enterococcus faecalis and Enterococcus faecium
Hendricks, O., Molnár, A., Butterworth, T. S., Butaye, P., Kolmos, H. J., Christensen, J. B., & Kristiansen, J. E. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960105.x · Cited by 15
A phenothiazine derivative reduces rat brain damage after global or focal ischemia.
Yu, M. J., McCowan, J. R., Smalstig, E. B., Bennett, D., Roush, M. E., & Clemens, J. A. (1992) · Stroke · doi:10.1161/01.str.23.9.1287 · Cited by 14
Kennedy, J., Tien, Y. Y., Cohen, L. J., Sclar, D. A., Liu, D., Blodgett, E. G., & Engle, J. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.12.017 · Cited by 13
Cited by
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“The AMY ITCs express high levels of MOR (Busti et al., 2011), and lesioning of MOR-expressing neurons in the ITCs following extinction training impairs extinction retrieval (Likhtik et al., 2008), indicating that MOR signaling in the ITCs contributes to extinction consolidates.”
BackgroundMethodDrug repurposing from an academic perspective
Oprea, T. I., Bauman, J. E., Bologa, C. G., Buranda, T., Chigaev, A., Edwards, B. S., Jarvik, J. W., Gresham, H. D., Haynes, M. K., Hjelle, B., et al. (2011) · Drug Discovery Today: Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.002 · Cited by 364
Pouyan, A., Ghorbanlo, M., Eslami, M., Jahanshahi, M., Ziaei, E., Salami, A., Mokhtari, K., Shahpasand, K., Farahani, N., Meybodi, T. E., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02267-0 · Cited by 271
Antifungal combinations in Mucorales: A microbiological perspective
Schwarz, P., Cornely, O. A., & Dannaoui, E. (2019) · Mycoses · doi:10.1111/myc.12909 · Cited by 43
Metadata
- Authors
- Ohlow, M. J., & Moosmann, B.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 16
- Issue
- 3-4
- Pages
- 119-131
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2032525332
- Cited by
- 280
- References
- 71
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.